Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

NCT07114315 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT07114315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07114315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Recruiting
Start date
September 19, 2025
Completion date
August 31, 2028
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer